Table 1.
List of potential outcomes
| Categories | Outcomes |
|---|---|
| Common signs and symptoms | Harris Hip Score (HHS) |
| Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) | |
| Visual analogue scale (VAS) | |
| Charnley score | |
| Merle D’Aubigne score | |
| Japanese Orthopedic Association Score (JOA) | |
| Method used to determine the percentage of adult ONFH | |
| Syndrome integral to TCM | |
| Clinical effective rate | |
| ROM of flexion | |
| Walking distance | |
| Degree of claudication | |
| Quality of life | MOS Short-Form Health Survey (SF-36) |
| 12-item Short-Form Health Survey (SF-12) | |
| Quality of Life Brief Scale (QOL-BREF) | |
| EORTC-30 Scale | |
| Barthel index | |
| Long-term outcomes | Femoral head survival time |
| Hip joint arthroplasty rate | |
| Femoral head collapse rate | |
| Femoral head survival rate | |
| Radiological evaluation | Degree of X-ray change |
| Degree of computed tomography (CT) change | |
| Degree of bone marrow edema | |
| Percentage of empty lacunae | |
| Sample line of magnetic resonance imaging (MRI) | |
| Necrotic bone resorption rate | |
| New bone repair rate | |
| Bone mineral density | |
| Blood biochemistry | Erythrocyte sedimentation rate (ESR) |
| Lipid indexes | |
| Bone Gla protein (BGP) | |
| Endothelin (ET) | |
| Bone morphogenetic protein 2 (BMP2) | |
| Osteoblasts (OB) | |
| Osteoclasts (OC) | |
| Osteoprotegerin (OPG) | |
| Alkaline phosphatase (ALP) | |
| C-reactive protein (CRP) | |
| Indexes of safety | Adverse effect rate |
| Adverse events | |
| Detection of blood biochemical indexes |